Gene Signal Company
Gene Signal is a biotechnology company that conducts research and development to discover genes that regulate angiogenesis. Their ophthalmic research program is focused on inhibiting Insulin Receptor Substrate 1 (IRS-1) to block pathological angiogenesis.
Estimated Revenue:
10.8B
Headquarters:
Vaud
Founded Date:
2000
Industry:
Gene Therapy